ARK bought 347,777 shares of GENI for ARKF.
- The trade: 0.24% of that fund, on 8 October 2026 — roughly $2.3m at that day’s close.
- The entry: GENI's close on 8 October 2026, $6.63. ARK discloses the fund, date, direction and share count -- never the price it paid -- and the notification posts after the close, so this is the closing print on the day they traded, not their actual fill. The first moment anyone reading could act on it was the next open.
Also bought that session: KYMR at 109.30 (0.22% of ARKG), KLAR at 13.46 (0.20% of ARKF), NRIX at 22.21 (0.16% of ARKG), SYM at 42.06 (0.14% of ARKQ), FRNM at 15.81 (0.05% of ARKG), PONY at 5.76 (0.03% of ARKQ). Each priced the same way — the close on the day ARK traded it.
Risk: ARK's file covers portfolio adjustments the investment team made -- it excludes creation and redemption activity, which moves an ETF's share counts without anyone deciding anything. Sales are not posted here: trimming a position is an exit, not a short. An automated tracker of public ARK Invest disclosures, not a recommendation. Not run by or affiliated with ARK Invest or Cathie Wood.
GE
Continue with Google